Agreement between different recall periods in drug utilization studies

Detalhes bibliográficos
Autor(a) principal: Moraes,Cassia Garcia
Data de Publicação: 2017
Outros Autores: Mengue,Sotero Serrate, Pizzol,Tatiane da Silva Dal
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista brasileira de epidemiologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324
Resumo: ABSTRACT: Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use.
id ABRASCO-1_3564965850e82ffdeb3cd987010c889c
oai_identifier_str oai:scielo:S1415-790X2017000200324
network_acronym_str ABRASCO-1
network_name_str Revista brasileira de epidemiologia (Online)
repository_id_str
spelling Agreement between different recall periods in drug utilization studiesDrug utilizationQuestionnairesSelf reportMental recallValidation studiesPharmacoepidemiologyABSTRACT: Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use.Associação Brasileira de Saúde Coletiva2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324Revista Brasileira de Epidemiologia v.20 n.2 2017reponame:Revista brasileira de epidemiologia (Online)instname:Associação Brasileira de Saúde Coletiva (ABRASCO)instacron:ABRASCO10.1590/1980-5497201700020012info:eu-repo/semantics/openAccessMoraes,Cassia GarciaMengue,Sotero SerratePizzol,Tatiane da Silva Daleng2017-08-17T00:00:00Zoai:scielo:S1415-790X2017000200324Revistahttp://www.scielo.br/rbepidhttps://old.scielo.br/oai/scielo-oai.php||revbrepi@usp.br1980-54971415-790Xopendoar:2017-08-17T00:00Revista brasileira de epidemiologia (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)false
dc.title.none.fl_str_mv Agreement between different recall periods in drug utilization studies
title Agreement between different recall periods in drug utilization studies
spellingShingle Agreement between different recall periods in drug utilization studies
Moraes,Cassia Garcia
Drug utilization
Questionnaires
Self report
Mental recall
Validation studies
Pharmacoepidemiology
title_short Agreement between different recall periods in drug utilization studies
title_full Agreement between different recall periods in drug utilization studies
title_fullStr Agreement between different recall periods in drug utilization studies
title_full_unstemmed Agreement between different recall periods in drug utilization studies
title_sort Agreement between different recall periods in drug utilization studies
author Moraes,Cassia Garcia
author_facet Moraes,Cassia Garcia
Mengue,Sotero Serrate
Pizzol,Tatiane da Silva Dal
author_role author
author2 Mengue,Sotero Serrate
Pizzol,Tatiane da Silva Dal
author2_role author
author
dc.contributor.author.fl_str_mv Moraes,Cassia Garcia
Mengue,Sotero Serrate
Pizzol,Tatiane da Silva Dal
dc.subject.por.fl_str_mv Drug utilization
Questionnaires
Self report
Mental recall
Validation studies
Pharmacoepidemiology
topic Drug utilization
Questionnaires
Self report
Mental recall
Validation studies
Pharmacoepidemiology
description ABSTRACT: Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use.
publishDate 2017
dc.date.none.fl_str_mv 2017-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1980-5497201700020012
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Saúde Coletiva
publisher.none.fl_str_mv Associação Brasileira de Saúde Coletiva
dc.source.none.fl_str_mv Revista Brasileira de Epidemiologia v.20 n.2 2017
reponame:Revista brasileira de epidemiologia (Online)
instname:Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
instname_str Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron_str ABRASCO
institution ABRASCO
reponame_str Revista brasileira de epidemiologia (Online)
collection Revista brasileira de epidemiologia (Online)
repository.name.fl_str_mv Revista brasileira de epidemiologia (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)
repository.mail.fl_str_mv ||revbrepi@usp.br
_version_ 1754212954968948736